Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03553654 · ClinicalTrials.gov registry record · NA
Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03553654 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 19 participants.
The verdict
NCT03553654, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Prospective single arm study to evaluate a low-dose CT-based protocol for early detection of myocardial dysfunction in 50 cancer patients undergoing anthracycline-based chemotherapy.
Interventions
- DIAGNOSTIC_TEST low dose CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2021-12-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03553654
The ClinicalTrials.gov registry entry for NCT03553654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which low dose CT is the first listed.
NCT03553654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03553654 about?
NCT03553654 is a clinical study titled "Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity". Prospective single arm study to evaluate a low-dose CT-based protocol for early detection of myocardial dysfunction in 50 cancer patients undergoing anthracycline-based chemotherapy.
What is the current status of trial NCT03553654?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-01-09. Estimated completion is 2021-12-12.
What interventions are being tested in trial NCT03553654?
The interventions under investigation include: low dose CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03553654?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.